<?xml version="1.0" encoding="UTF-8"?>
<p id="p0520">There are currently 21 COVID-19 vaccines candidates in clinical trials, including four funded by CEPI (including the mRNA (the first to enter clinical trials, co-developed with the National Institute of Allergy and Infectious Diseases (NIAID), USA), DNA, ChAdOx1-S and protein subunit vaccine) as shown in 
 <xref rid="t0005" ref-type="table">Table 1</xref>
 <xref rid="b0020" ref-type="bibr">[4]</xref>, 
 <xref rid="b0025" ref-type="bibr">[5]</xref>. 
 <xref rid="t0010" ref-type="table">Table 2</xref> shows the candidates in preclinical development 
 <xref rid="b0020" ref-type="bibr">[4]</xref>, 
 <xref rid="b0025" ref-type="bibr">[5]</xref>.
</p>
